Hepatocyte Growth Hormone Receptor Ablation Is Associated With Aging Phenotypes and Hepatic Mitochondrial Dysfunction
Key claim: Hepatocyte-specific ablation of the growth hormone receptor is associated with aging phenotypes and hepatic mitochondrial dysfunction.
Abstract
Aging Cell, Volume 25, Issue 10, October 2026.
Why this matters
Systemic GH/IGF-1 reduction is one of the most reproducible longevity levers across models, but this finding localizes part of that signal to hepatocyte-autonomous GH receptor loss — with hepatic mitochondrial dysfunction as a co-occurring lesion rather than an unambiguous benefit. That complicates the clean ‘less GH = longer life’ narrative used to justify GH-axis suppression, since the same receptor loss in liver couples to mitochondrial impairment and aging phenotypes. It sharpens where in the GH axis interventions should and shouldn’t act.